Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / Common Shares, par value US$0.001 per share
-
Shares outstanding
-
71,872,133
-
Total 13F shares
-
12,473,872
-
Share change
-
-15,140
-
Total reported value
-
$76,374,256
-
Put/Call ratio
-
151%
-
Price per share
-
$6.12
-
Number of holders
-
40
-
Value change
-
-$92,057
-
Number of sells
-
2
Institutional Holders of SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) as of Q4 2013
As of 31 Dec 2013,
SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,473,872 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT CO LLP, ORBIMED ADVISORS LLC, DAVIS SELECTED ADVISERS, FIL Ltd, RENAISSANCE TECHNOLOGIES LLC, Visium Asset Management, LP, BlackRock Fund Advisors, Pine River Capital Management L.P., PICTET ASSET MANAGEMENT LTD, and Invesco Ltd..
This page lists
40
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.